CDAK
Codiak BioSciences, Inc.
Price:  
0.06 
USD
Volume:  
13,642,300.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CDAK EV/EBITDA

-19154.4%
Upside

As of 2025-07-09, the EV/EBITDA ratio of Codiak BioSciences, Inc. (CDAK) is 0.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CDAK's latest enterprise value is -21.30 mil USD. CDAK's TTM EBITDA according to its financial statements is -62.43 mil USD. Dividing these 2 quantities gives us the above CDAK EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.3x - 16.7x 13.9x
Forward P/E multiples 10.9x - 26.1x 16.0x
Fair Price (9.63) - (12.13) (10.86)
Upside -16988.2% - -21386.1% -19154.4%
0.06 USD
Stock Price
(10.86) USD
Fair Price

CDAK EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA